The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index; none of the 118 sources its claims cite is checked for support yet.
Mechanisms of Antibiotic Resistance
Open accessAbstract
Emergence of resistance among the most important bacterial pathogens is recognized as a major public health threat affecting humans worldwide. Multidrug-resistant organisms have not only emerged in the hospital environment but are now often identified in community settings, suggesting that reservoirs of antibiotic-resistant bacteria are present outside the hospital. The bacterial response to the antibiotic “attack” is the prime example of bacterial adaptation and the pinnacle of evolution. “Survival of the fittest” is a consequence of an immense genetic plasticity of bacterial pathogens that trigger specific responses that result in mutational adaptations, acquisition of genetic material, or alteration of gene expression producing resistance to virtually all antibiotics currently available in clinical practice. Therefore, understanding the biochemical and genetic basis of resistance is of paramount importance to design strategies to curtail the emergence and spread of resistance and to devise innovative therapeutic approaches against multidrug-resistant organisms. In this chapter, we will describe in detail the major mechanisms of antibiotic resistance encountered in clinical practice, providing specific examples in relevant bacterial pathogens.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This review describes the major genetic and biochemical mechanisms by which bacteria resist antibiotics, including drug modification/destruction, reduced penetration and efflux, target alteration/protection/bypass, and global cell adaptations. It emphasizes acquired resistance through mutation and horizontal gene transfer and illustrates these mechanisms with clinically important examples such as β-lactamases, vancomycin resistance, daptomycin resistance, and linezolid resistance.
Key findings
- Acquired resistance can arise from chromosomal mutations or acquisition of foreign DNA via horizontal gene transfer, including transformation, transduction, conjugation, mobile genetic elements, and integrons.
- The paper classifies resistance mechanisms into four broad biochemical categories: (i) modification or destruction of the antibiotic, e.g., aminoglycoside-modifying enzymes, chloramphenicol acetyltransferases, and β-lactamases, with more than 1,000 β-lactamases described and 22 variants of *bla*KPC reported; (ii) decreased penetration or efflux, involving porins and five major efflux pump families (MFS, SMR, RND, ABC, MATE); (iii) target-site changes, including protection (TetM/TetO, Qnr), modification (*rpoB* for rifampin, *gyrA*/*parC* for fluoroquinolones, 23S rRNA/L3/L4 for linezolid, *erm* methylation), and replacement/bypass (*mecA*/PBP2a, *van* clusters, DHFR/DHPS overproduction); and (iv) global cell adaptations, such as LiaFSR, YycFG/WalKR, VraTSR, MprF, and *rpoB* changes in daptomycin and vancomycin-intermediate resistance.
- The paper reports that the WHO named antibiotic resistance one of the three most important public health threats of the 21st century; MDR infections carry an economic burden estimated at over $20 billion per year in the US; the CDC conservatively estimates at least 23,000 deaths annually in the USA from antibiotic-resistant infections; and one report estimates around 300 million premature deaths by 2050 with up to $100 trillion in global economic loss.
- Specific examples include MRSA via *mecA*-encoded PBP2a; enterococcal vancomycin resistance via nine described *van* clusters, with D-Ala-D-Lac replacement decreasing vancomycin affinity about 1,000-fold; hVISA/VISA isolates with vancomycin MICs of 4–8 μg/mL; and daptomycin resistance where a LiaF deletion increased the MIC from 1 to 4 μg/mL and abolished bactericidal activity, while 75% of daptomycin-susceptible *E. faecium* isolates with MICs between 3 and 4 μg/mL harbored LiaFSR mutations.
Methods
- Narrative review chapter; no primary experimental design, sample, or statistical analysis is reported.
- It synthesizes published literature and provides mechanistic examples from clinically relevant bacteria, without stating a systematic search strategy or inclusion criteria.
- The main analysis is a conceptual classification of resistance mechanisms into genetic bases (mutation versus horizontal gene transfer) and four biochemical categories, illustrated with selected clinical examples.
Limitations
- The paper does not state a limitations section.
- Evident from the text: it is a narrative review rather than a systematic review, examples are selected for clinical relevance, and no primary data or quantitative synthesis are presented.
- The paper also notes that some mechanisms remain incompletely understood, such as the exact mechanism by which LiaFSR mediates daptomycin resistance, the function of VanZ, and how *rpoB* mutations lead to reduced vancomycin and daptomycin susceptibility.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 118 cited sources checked · 0 supported · 0 flagged
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The establishment of clinical susceptibility breakpoints (susceptible, intermediate and resistant) mainly relies on the in vitro activity of an antibiotic against a sizeable bacterial sample, combined with some pharmacological parameters (e.g., blood and infection site concentrations of the antimicrobial, among others).”
§ Mechanisms of Antibiotic Resistance > INTRODUCTION
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Likewise, the innate low susceptibility of Pseudomonas and Acinetobacter baumanii to β-lactams (compared to Enterobacteriaceae) can be explained, at least in part, to a reduced number and/or differential expression of porins (38).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > II. Decreased Antibiotic Penetration and Efflux
What the sources say
- Not checked yetcites [38] Hancock RE Brinkman FS Function of pseudomonas porins in uptake and efflux Annu Rev Microbiol 2002 56 17 38 12142471 source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“More recently (2008), a new carbapenemase was identified in a K. pneumoniae isolate recovered from a Swedish patient who had been previously admitted to a hospital in New Delhi, India.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > I. Modifications of the Antibiotic Molecule
What the sources say
- Not checked yetcites [29] Kumarasamy KK Toleman MA Walsh TR Bagaria J Butt F Balakrishnan R Chaudhary U Doumith M Giske CG Irfan S Krishnan P Kumar AV Maharjan S Mushtaq S Noorie T Paterson DL Pearson A Perry C Pike R Rao B Ray U Sarma JB Sharma M Sheridan E Thirunarayan MA Turton J Upadhyay S Warner M Welfare W Livermore DM Woodford N Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study Lancet Infect Dis 2010 9 10 9 597 602 20705517 PMC2933358 source
Strength:plain· not yet calibratedSingle caseTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“In addition, the in vivo susceptibility of an organism to a particular antibiotic may vary according to the size of the bacterial inoculum, a situation that has been well documented in Staphylococcus aureus infections with some cephalosporins.”
§ Mechanisms of Antibiotic Resistance > INTRODUCTION
What the sources say
- Not checked yetcites [8] Nannini EC Singh KV Arias CA Murray BE In vivo effect of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible Staphylococcus aureus strain showing an inoculum effect against cefazolin Antimicrob Agents Chemother 2013 57 9 4276 81 PMC3754321 23796934 source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Hydrophilic molecules such as β-lactams, tetracyclines and some fluoroquinolones are particularly affected by changes in permeability of the outer membrane since they often use water-filled diffusion channels known as porins to cross this barrier (37).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > II. Decreased Antibiotic Penetration and Efflux
What the sources say
- Not checked yetcites [37] Pagès JM James CE Winterhalter M The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria Nat Rev Microbiol 2008 12 6 12 893 903 18997824 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The prime example of the efficiency of this natural barrier is the fact that vancomycin, a glycopeptide antibiotic, is not active against gram-negative organisms due to the lack of penetration through the outer membrane.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > II. Decreased Antibiotic Penetration and Efflux
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“These enzymes destroy the amide bond of the β-lactam ring, rendering the antimicrobial ineffective.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > I. Modifications of the Antibiotic Molecule
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The production of enzymes capable of introducing chemical changes to the antimicrobial molecule is a well-known mechanism of acquired antibiotic resistance in both gram-negative and gram-positive bacteria.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > I. Modifications of the Antibiotic Molecule
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Among the best-characterized porins, the three major proteins produced by E. coli (known as OmpF, OmpC and PhoE) and the P. aeruginosa OprD (also known as protein D2) are classical examples of porin-mediated antibiotic resistance.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > II. Decreased Antibiotic Penetration and Efflux
What the sources say
- Not checked yetcites [39] Nikaido H Molecular basis of bacterial outer membrane permeability revisited Microbiol Mol Biol Rev 2003 12 67 4 593 656 14665678 PMC309051 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Thus, when treating antibiotic-resistant bacteria, the interpretation of susceptibility patterns may vary according to the clinical scenario and the availability of treatment options.”
§ Mechanisms of Antibiotic Resistance > INTRODUCTION
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes
- It may state two separate claims as one. 74
- Probably not a substantial claim. 27
- The quote only partly states this claim. 1
In the paper
“Importantly, changes in permeability through any of these mechanisms frequently result in low-level resistance and are often associated with other mechanisms of resistance, such as increased expression of efflux pumps (see below) (39).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > II. Decreased Antibiotic Penetration and Efflux
What the sources say
- Not checked yetcites [39] Nikaido H Molecular basis of bacterial outer membrane permeability revisited Microbiol Mol Biol Rev 2003 12 67 4 593 656 14665678 PMC309051 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“These enzymes can be divided into serine carbapenemases (Ambler class A or D) and metallo-carbapenemases (Ambler class B enzymes).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > I. Modifications of the Antibiotic Molecule
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“From an evolutionary perspective, bacteria use two major genetic strategies to adapt to the antibiotic “attack”, i) mutations in gene(s) often associated with the mechanism of action of the compound, and ii) acquisition of foreign DNA coding for resistance determinants through horizontal gene transfer (HGT).”
§ Mechanisms of Antibiotic Resistance > GENETIC BASIS OF ANTIMICROBIAL RESISTANCE
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Alterations of porins could be achieved by 3 general processes, i) a shift in the type of porins expressed, ii) a change in the level of porin expression, and iii) impairment of the porin function.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > II. Decreased Antibiotic Penetration and Efflux
What the sources say
- Not checked yetcites [39] Nikaido H Molecular basis of bacterial outer membrane permeability revisited Microbiol Mol Biol Rev 2003 12 67 4 593 656 14665678 PMC309051 source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Bacteria have developed mechanisms to prevent the antibiotic from reaching its intracellular or periplasmic target by decreasing the uptake of the antimicrobial molecule. This mechanism is particularly important in gram-negative bacteria (for the reason specified above), limiting the influx of substances from the external milieu.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > II. Decreased Antibiotic Penetration and Efflux
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Furthermore, the presence of this bifunctional enzyme accounts for most of high-level gentamicin resistance detected in enterococci (including in vancomycin-resistant strains) and methicillin-resistant S. aureus worldwide (13).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > I. Modifications of the Antibiotic Molecule
What the sources say
- Not checked yetcites [13] Hollenbeck BL Rice LB Intrinsic and acquired resistance mechanisms in enterococcus Virulence 2012 8 15 3 5 421 33 23076243 PMC3485979 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Class C β-lactamases confer resistance to all penicillins and cephalosporins (although cefepime is usually a poor substrate), including cephamycins. They do not reliably hydrolyze aztreonam and are not inhibited by clavulanic acid.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > I. Modifications of the Antibiotic Molecule
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“In fact, the World Health Organization has named antibiotic resistance as one of the three most important public health threats of the 21st century (1).”
§ Mechanisms of Antibiotic Resistance > INTRODUCTION
What the sources say
- Not checked yetcites [1] Antimicrobial resistance: global report on surveillance 2014 World Health Organization 2014 Downloaded from http://www.who.int/drugresistance/documents/surveillancereport/en/, last accessed on March 4, 2015
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“On the other hand, the Bush-Jacoby classification divides β-lactamases into 4 categories (each with several subgroups) according to their biochemical function, mainly based on substrate specificity (19, 20).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > I. Modifications of the Antibiotic Molecule
What the sources say
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“As it will be discussed later in the chapter, the development of acquired resistance can be the result of mutations in chromosomal genes or due to the acquisition of external genetic determinants of resistance, likely obtained from intrinsically resistant organisms present in the environment.”
§ Mechanisms of Antibiotic Resistance > INTRODUCTION
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Infections caused by multidrug-resistant (MDR) organisms are associated with increased mortality compared to those caused by susceptible bacteria and they carry an important economic burden, estimated at over 20 billion dollars per year in the US only (2,3,4).”
§ Mechanisms of Antibiotic Resistance > INTRODUCTION
What the sources say
- Not checked yetcites [2] Cosgrove SE The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs Clin Infect Dis 2006 1 15 42 Suppl 2 S82 9 16355321 source
- Not checked yetcites [3] DiazGranados CA Zimmer SM Klein M Jernigan JA Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis Clin Infect Dis 2005 8 1 41 3 327 33 16007529 source
- Not checked yetcites [4] Sydnor ER Perl TM Hospital epidemiology and infection control in acute-care settings Clin Microbiol Rev 2011 1 24 1 141 73 21233510 PMC3021207 source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“First, the Ambler classification relies on amino acid sequence identity and separates β-lactamases into 4 groups (A, B, C, and D).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > I. Modifications of the Antibiotic Molecule
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Most antimicrobial compounds are naturally-produced molecules, and, as such, co-resident bacteria have evolved mechanisms to overcome their action in order to survive.”
§ Mechanisms of Antibiotic Resistance > INTRODUCTION
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
In the paper
“KPC was first reported in 1996 from a K. pneumoniae recovered from a patient in North Carolina, USA (25).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > I. Modifications of the Antibiotic Molecule
What the sources say
- Not checked yetcites [25] Yigit H Queenan AM Anderson GJ Domenech-Sanchez A Biddle JW Steward CD Alberti S Bush K Tenover FC Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae Antimicrob Agents Chemother 2001 4 45 4 1151 61 11257029 PMC90438 source
Strength:plain· not yet calibratedSingle caseTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“First, antimicrobial resistance is ancient and it is the expected result of the interaction of many organisms with their environment.”
§ Mechanisms of Antibiotic Resistance > INTRODUCTION
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Nevertheless, NDM-1 rapidly spread around the globe, becoming a prime example of how a resistance determinant can readily disseminate worldwide despite many efforts to avoid its transmission.”
- Also stated in: § I. Modifications of the Antibiotic Molecule · plain
“Thus, the presence of NDM-1 is frequently accompanied by a multidrug-resistant phenotype.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > I. Modifications of the Antibiotic Molecule
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one. The quote only partly states this claim.
- Also stated in: § I. Modifications of the Antibiotic Molecule · plain
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Classically, bacteria acquire external genetic material through three main strategies, i) transformation (incorporation of naked DNA), ii) transduction (phage mediated) and, iii) conjugation (bacterial “sex”).”
§ Mechanisms of Antibiotic Resistance > GENETIC BASIS OF ANTIMICROBIAL RESISTANCE > Horizontal Gene Transfer
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Of note, resistance to one antimicrobial class can usually be achieved through multiple biochemical pathways, and one bacterial cell may be capable of using a cadre of mechanisms of resistance to survive the effect of an antibiotic.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“The Centers for Disease Control and Prevention conservatively estimates that at least 23,000 people die annually in the USA as a result of an infection with an antibiotic-resistant organism (5).”
§ Mechanisms of Antibiotic Resistance > INTRODUCTION
What the sources say
- Not checked yetcites [5] Antibiotic Resistance Threats in the United States Centers for Disease Control and Prevention 2013 Downloaded from http://www.cdc.gov/drugresistance/threat-report-2013/index.html, last accessed on March 9, 2015
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Class D β-lactamases include a wide range of enzymes that were initially differentiated from the class A penicillinases due to their ability to hydrolyze oxacillin (hence their name) and because they were poorly inhibited by clavulanic acid.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > I. Modifications of the Antibiotic Molecule
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Acquisition of foreign DNA material through HGT is one of the most important drivers of bacterial evolution and it is frequently responsible for the development of antimicrobial resistance.”
§ Mechanisms of Antibiotic Resistance > GENETIC BASIS OF ANTIMICROBIAL RESISTANCE > Horizontal Gene Transfer
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Moreover, according to a recent report, antibiotic resistance is estimated to cause around 300 million premature deaths by 2050, with a loss of up to $100 trillion (£64 trillion) to the global economy (6).”
§ Mechanisms of Antibiotic Resistance > INTRODUCTION
What the sources say
- Not checked yetcites [6] Antimicrobial Resistance: Tackling a Crisis for the Future Health and Wealth of Nations 2014 Downloaded from http://amr-review.org/, last accessed on March 11, 2015
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“For example, the predominant mechanism of resistance to β-lactams in gram-negative bacteria is the production of β-lactamases, whereas resistance to these compounds in gram-positive organisms is mostly achieved by modifications of their target site, the penicillin-binding proteins (PBPs).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The expression of ampC is generally inducible and is under strict control of a complex regulatory mechanism that has been best studied in Enterobacter spp.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > I. Modifications of the Antibiotic Molecule
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“As a general rule, conjugation uses mobile genetic elements (MGEs) as vehicles to share valuable genetic information, although direct transfer from chromosome to chromosome has also been well characterized (9).”
§ Mechanisms of Antibiotic Resistance > GENETIC BASIS OF ANTIMICROBIAL RESISTANCE > Horizontal Gene Transfer
What the sources say
- Not checked yetcites [9] Manson JM Hancock LE Gilmore MS Mechanism of chromosomal transfer of Enterococcus faecalis pathogenicity island, capsule, antimicrobial resistance, and other traits Proc Natl Acad Sci U S A 2010 7 6 107 27 12269 74 20566881 PMC2901427 source
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“From then on, the development of newer generations of β-lactams has systematically been followed by the rapid appearance of enzymes capable of destroying any novel compound that reach the market, in a process that is a prime example of antibiotic-driven adaptive bacterial evolution.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > I. Modifications of the Antibiotic Molecule
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Finally, one of the most efficient mechanisms for accumulating antimicrobial resistance genes is represented by integrons, which are site-specific recombination systems capable of recruiting open reading frames in the form of mobile gene cassettes.”
§ Mechanisms of Antibiotic Resistance > GENETIC BASIS OF ANTIMICROBIAL RESISTANCE > Horizontal Gene Transfer
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Unfortunately, the marked increase in antimicrobial resistance among common bacterial pathogens is now threatening this therapeutic accomplishment, jeopardizing the successful outcomes of critically ill patients.”
§ Mechanisms of Antibiotic Resistance > INTRODUCTION
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“One of the best examples of resistance via modification of the drug is the presence of aminoglycoside modifying enzymes (AMEs) that covalently modify the hydroxyl or amino groups of the aminoglycoside molecule. Multiple AMEs have been described to date and they have become the predominant mechanism of aminoglycoside resistance worldwide.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > I. Modifications of the Antibiotic Molecule
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Other clinically relevant group of enzymes is the carbapenemases (a diverse group of β-lactamases with the ability to hydrolyze carbapenems), the most potent β-lactams available in clinical practice.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > I. Modifications of the Antibiotic Molecule
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“In contrast to other Ambler class A ESBLs like TEM-3, this enzyme did not derive from TEM or SHV, rather, the current evidence suggests that it was likely acquired from Kluyvera spp. (an environmental bacterium with no major human pathogenic significance) through HGT (22).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > I. Modifications of the Antibiotic Molecule
What the sources say
- Not checked yetcites [22] Bonnet R Growing group of extended-spectrum beta lactamases: the CTX-M enzymes Antimicrob Agents Chemother 2004 1 48 1 1 14 14693512 PMC310187 source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“As an example, fluoroquinolone (FQ) resistance can occur due to three different biochemical routes, all of which may coexist in the same bacteria at a given time (producing an additive effect and, often, increasing the levels of resistance), i) mutations in genes encoding the target site of FQs (DNA gyrase and topoisomerase IV), ii) over-expression of efflux pumps that extrude the drug from the”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Although some of the genetic determinants coding for proteins that mediate target protection have been found in the bacterial chromosome, most of the clinically relevant genes involved in this mechanism of resistance are carried by MGEs.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“The cfr gene is a plasmid-borne determinant initially described in 2000 in a bovine isolate of Staphylococcus sciuri and first reported in humans in 2005 in an S. aureus isolated from a patient in Colombia (66).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
What the sources say
- Not checked yetcites [66] Toh SM Xiong L Arias CA Villegas MV Lolans K Quinn J Mankin AS Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid Mol Microbiol 2007 64 6 1506 14 17555436 PMC2711439 source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“High-level RIF resistance has been shown to occur by single-step point mutations resulting in amino acid substitutions in the rpoB gene and many different genetic changes have been reported.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Introducing modifications to the target site is one of the most common mechanisms of antibiotic resistance in bacterial pathogens affecting almost all families of antimicrobial compounds.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“Of note, while these mutations result in decreased affinity of the drug for its target, they usually spare the catalytic activity of the polymerase, permitting transcription to continue (58).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
What the sources say
- Not checked yetcites [58] Floss HG Yu TW Rifamycin-mode of action, resistance, and biosynthesis Chem Rev 2005 2 105 2 621 32 15700959 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The post-therapy isolates were found to exhibit a shift in porin expression from OmpK35 to OmpK36 (the latter possessing a smaller channel size).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > II. Decreased Antibiotic Penetration and Efflux
What the sources say
- Not checked yetcites [41] Hasdemir UO Chevalier J Nordmann P Pagès JM Detection and prevalence of active drug efflux mechanism in various multidrugresistant Klebsiella pneumoniae strains from Turkey J Clin Microbiol 42 2701 2706 2004 15184455 PMC427859 source
- Not checked yetcites [42] Doménech-Sánchez A Martínez-Martínez L Hernández-Allés S del Carmen Conejo M Pascual A Tomás JM Albertí S Benedí VJ Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance Antimicrob Agents Chemother 47 3332 3335 2003 14506051 PMC201126 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Similarly, TetO has also been shown to compete with tetracycline for the same ribosomal space and to alter the geometry of the binding site of the antibiotic, displacing the molecule from the ribosome and allowing protein synthesis to resume (53).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
What the sources say
- Not checked yetcites [53] Li W Atkinson GC Thakor NS Allas U Lu CC Chan KY Tenson T Schulten K Wilson KS Hauryliuk V Frank J Mechanism of tetracycline resistance by ribosomal protection protein Tet(O) Nat Commun 2013 4 1477 23403578 PMC3576927 source
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Tet(M) was initially described in Streptococcus spp. and Tet(O) in Campylobacter jejuni, but they are now both widely distributed among different bacterial species, likely because they have been found in several plasmids and in broad-range conjugative transposons (51).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
What the sources say
- Not checked yetcites [51] Connell SR Tracz DM Nierhaus KH Taylor DE Ribosomal protection proteins and their mechanism of tetracycline resistance Antimicrob Agents Chemother 2003 12 47 12 3675 81 14638464 PMC296194 source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Importantly, many of these pumps affect tetracycline and doxycycline, but do not decrease minocycline or tigecycline susceptibility, as they are not able to use these compounds as substrates (44, 47).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > II. Decreased Antibiotic Penetration and Efflux
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Thus, in contrast to the case of RIF, clinically relevant FQ resistance frequently requires an accumulation of genetic changes over time, with the first mutation producing minor increases in the MIC (59).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
What the sources say
- Not checked yetcites [59] Hooper DC Fluoroquinolone resistance among Gram-positive cocci Lancet Infect Dis 2002 9 2 9 530 8 12206969 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Resistance to methicillin (a semisynthetic penicillin stable against the staphylococcal penicillinase) in S. aureus results from the acquisition of a foreign gene (likely from Staphylococcus sciuri) designated mecA often located in a large DNA fragment designated staphylococcal chromosomal cassette mec (SCCmec).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Indeed, they have shown that AcrB has two binding pockets with different substrate preferences and that compounds are moved out of the cell through a series of conformational changes in a functionally rotating mechanism that finishes with the substrate being extruded via TolC (a process that requires an interaction with the periplasmic accessory protein AcrA) (Du D Nature 2014).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > II. Decreased Antibiotic Penetration and Efflux
What the sources say
- Not checked yetcites Du D Nature 2014
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“RIF binding pocket is a highly conserved structure located in the β subunit of the RNA polymerase (encoded by rpoB), and after binding, the antibiotic molecule interrupts transcription by directly blocking the path of the nascent RNA (57).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
What the sources say
- Not checked yetcites [57] Campbell EA Korzheva N Mustaev A Murakami K Nair S Goldfarb A Darst SA Structural mechanism for rifampicin inhibition of bacterial rna polymerase Cell 2001 3 23 104 6 901 12 11290327 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“These target changes may consist of i) point mutations in the genes encoding the target site, ii) enzymatic alterations of the binding site (e.g. addition of methyl groups), and/or iii) replacement or bypass of the original target.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“These systems may be substrate-specific (for a particular antibiotic such as tet determinants for tetracycline and mef genes for macrolides in pneumococci) or with broad substrate specificity, which are usually found in MDR bacteria (44).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > II. Decreased Antibiotic Penetration and Efflux
What the sources say
- Not checked yetcites [44] Poole K Efflux-mediated antimicrobial resistance J Antimicrob Chemother 2005 7 56 1 20 51 15914491 source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“There are 5 major families of efflux pumps, including i) the major facilitator superfamily (MFS), ii) the small multidrug resistance family (SMR), iii) the resistance-nodulation-cell-division family (RND), iv) the ATP-binding cassette family (ABC), and v) the multidrug and toxic compound extrusion family (MATE).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > II. Decreased Antibiotic Penetration and Efflux
What the sources say
- Not checked yetcites [46] Piddock LJ Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria Clin Microbiol Rev 2006 4 19 2 382 402 16614254 PMC1471989 source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Dönhöfer et al. recently showed that TetM directly dislodges and releases tetracycline from the ribosome by an interaction between the domain IV of the 16S rRNA and the tetracycline binding site. Furthermore, this interaction alters the ribosomal conformation, preventing rebinding of the antibiotic (52).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
What the sources say
- Not checked yetcites [52] Dönhöfer A Franckenberg S Wickles S Berninghausen O Beckmann R Wilson DN Structural basis for TetM-mediated tetracycline resistance Proc Natl Acad Sci USA 2012 10 16 109 42 16900 5 23027944 PMC3479509 source
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“To date, nine distinct enterococcal van clusters have been described (vanA, vanB, vanC, vanD, vanE, vanG, vanL, vanM and vanN).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“It has been postulated that the main effect of the binding of vancomycin to D-Ala-D-Ala-ending precursors emerging from the cytoplasm is alteration of transglycosylation (presumably due to steric hindrance) preventing further processing of the cell wall and leading to bacterial death (72).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
What the sources say
- Not checked yetcites [72] Reynolds PE Structure, biochemistry and mechanism of action of glycopeptide antibiotics Eur J Clin Microbiol Infect Dis 1989 11 8 11 943 50 2532132 source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Indeed, a recent report described such phenomenon where the vanA gene cluster was harbored in a highly transferable staphylococcal plasmid originally identified in community-associated S. aureus isolates. The isolate was found in a bloodstream isolate of MRSA recovered from a Brazilian patient (80) and transfer to a methicillin-susceptible isolate within the same patient was also documented.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
What the sources say
- Not checked yetcites [80] Rossi F Diaz L Wollam A Panesso D Zhou Y Rincon S Narechania A Xing G Di Gioia TS Doi A Tran TT Reyes J Munita JM Carvajal LP Hernandez-Roldan A Brandão D van der Heijden IM Murray BE Planet PJ Weinstock GM Arias CA Transferable vancomycin resistance in a community-associated MRSA lineage N Engl J Med 2014 370 16 1524 31 24738669 PMC4112484 source
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“However, unlike β-lactams, glycopeptides do not directly interact with PBPs. Instead, they bind to the terminal D-alanine-D-alanine (D-Ala-D-Ala) of the pentapeptide moiety of the nascent peptidoglycan precursors (lipid II), preventing PBP-mediated cross-linking and resulting in inhibition of cell wall synthesis.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Development of resistance to daptomycin (DAP) and vancomycin (low-level in S. aureus) are the most clinically relevant examples of resistance phenotypes that are the result of a global cell adaptive response to the antibacterial attack.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Interestingly, enterococci use another “bypass” strategy by incorporating exogenous tetrahydrofolic acid and folinic acid when added to the media. This ability to use folate from different sources is correlated with up to 25-fold increase in the MICs of TMP-SMX and are thought to impair the antimicrobial activity in vivo (84, 85).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
What the sources say
- Not checked yetcites [84] Hamilton-Miller JM Reversal of activity of trimethoprim against Gram-positive cocci by thymidine, thymine and ‘folates’ J Antimicrob Chemother 1988 22 35 9 3170389 source
- Not checked yetcites [85] Zervos MJ Schaberg DR Reversal of the in vitro susceptibility of enterococci to trimethoprim – sulfamethoxazole by folinic acid Antimicrob Agents Chemother 1985 28 446 8 3935044 PMC180272 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The vanADLM clusters synthesize precursors ending in D-Lac whereas the vanCEGN produce D-Ser-ending peptidoglycan.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Most clinical VRE isolates carry the vanA or vanB gene clusters, which are usually found in MGEs either associated with plasmids or inserted in the chromosome.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Indeed, community-associated MRSA strains appear to harbor shorter SCCmec cassettes (e.g SCCmec type IV) and carry less antibiotic resistance determinants, whereas hospital-associated (HA) isolates possess longer elements (e.g. SCCmec type II) and are usually multidrug resistant (70).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
What the sources say
- Not checked yetcites [70] Chambers HF Deleo FR Waves of resistance: Staphylococcus aureus in the antibiotic era Nat Rev Microbiol 2009 7 9 629 41 19680247 PMC2871281 source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The prototypical gene cluster responsible for low-level vancomycin resistance and the production of D-Ala-D-Ser peptidoglycan precursors is vanC.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“Development of high-level vancomycin resistance in S. aureus (vancomycin-resistant S. aureus, VRSA) was first described in 2002 and was the result of acquisition by an MRSA strain of the vanA gene cluster from a VRE (E. faecalis) isolate (79).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
What the sources say
- Not checked yetcites [79] Sievert DM Rudrik JT Patel JB McDonald LC Wilkins MJ Hageman JC Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006 Clin Infect Dis 2008 46 5 668 74 18257700 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Acquisition of mecA renders most β-lactams useless against MRSA and alternative therapies need to be used in serious infections.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Although the change of D-Ala for D-Ser does not remove any of the 5 hydrogen bonds between vancomycin and its target, the presence of the hydroxyl group of serine affects the interaction of the antibiotic with the precursors reducing its affinity, albeit less markedly than with the D-Lac replacement (74).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
What the sources say
- Not checked yetcites [74] Miller WR Munita JM Arias CA Mechanisms of antibiotic resistance in enterococci Expert Rev Anti Infect Ther 2014 10 12 10 1221 36 25199988 PMC4433168 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The vanX gene encodes a D,D-dipeptidase that hydrolyzes any D-Ala-D-Ala produced in the “normal” peptidoglycan synthesis pathway and vanY codes for a membrane-bound D,D-carboxypeptidase that removes the last D-Ala of normal ending precursors, ensuring that no D-Ala-D-Ala-ending pentapeptides (that could potentially bind vancomycin) are exposed on the cell surface.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Finally, Tn1546 harbors another gene (designated vanZ) that appears to be involved in teicoplanin resistance (but not vancomycin) whose function is unknown (76).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
What the sources say
- Not checked yetcites [76] Courvalin P Vancomycin resistance in gram-positive cocci Clin Infect Dis 2006 42 S25 34 16323116 source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“More importantly, these changes were sufficient to abolish the in vitro bactericidal activity of DAP and were associated with a clinical failure in a neutropenic patient with VRE bacteremia (92).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
What the sources say
- Not checked yetcites [92] Munita JM Mishra NN Alvarez D Tran TT Diaz L Panesso D Reyes J Murray BE Adachi JA Bayer AS Arias CA Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible Enterococcus faecium harboring LiaSR substitutions Clin Infect Dis 2014 59 9 1277 80 25107294 PMC4271039 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In B. subtilis, the lia locus consists of six genes, liaIH-liaGFSR, of which liaGFSR are constitutively expressed at a low basal level due to the presence of a weak constitutive promoter upstream of liaG.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
What the sources say
- Not checked yetcites [93] Wolf D Kalamorz F Wecke T Juszczak A Mäder U Homuth G Jordan S Kirstein J Hoppert M Voigt B Hecker M Mascher T In-depth profiling of the LiaR response of Bacillus subtilis J Bacteriol 2010 9 192 18 4680 93 20639339 PMC2937411 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Indeed, a single deletion of an isoleucine at position 177 of LiaF increased the DAP MIC from 1 to 4 μg/mL (established clinical breakpoint is 4 μg/ml) and, more importantly, was sufficient to abolish the bactericidal activity of DAP (89).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
What the sources say
- Not checked yetcites [89] Munita JM Tran TT Diaz L Panesso D Reyes J Murray BE Arias CA A liaF codon deletion abolishes daptomycin bactericidal activity against vancomycin-resistant Enterococcus faecalis Antimicrob Agents Chemother 2013 6 57 6 2831 3 23507277 PMC3716119 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The main differences in terms of gene content and biochemical activities of VanC-type mediated resistance compared with VanA and VanB are, i) they encode a unique racemase (VanT) capable of producing D-serine using L-serine as substrate, ii) they possess a ligase (vanCEGLN) with the ability to synthesize a D-Ala-D-Ser dipeptides, and iii) they often harbor a single gene (vanXY) encoding both D-Ala”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The vanA gene cluster is usually located on a Tn3-family transposon designated Tn1546, which has been found on both conjugative and non-conjugative plasmids.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“This drug impairs bacterial synthesis of purines and some important amino acids by altering the production of folate, exploiting the fact that most bacteria are unable to incorporate folate from external sources.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Vancomycin resistance is especially relevant in enterococci (particularly E. faecium) and it is usually accompanied by the presence of other resistance determinants, making the treatment of infections caused by these organisms an important clinical challenge (73).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
What the sources say
- Not checked yetcites [73] Arias CA Murray BE The rise of the Enterococcus: beyond vancomycin resistance Nat Rev Microbiol 2012 10 266 78 22421879 PMC3621121 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“This initial step results in an ATP-dependent phosphorylation of the response regulator VanR, which subsequently binds to two promoters, one of them located upstream of its own gene (vanR) and the other upstream of vanH in Tn1546 (78).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
What the sources say
- Not checked yetcites [78] Arthur M Molinas C Courvalin P The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147 J Bacteriol 1992 4 174 8 2582 91 1556077 PMC205897 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The synthetic pathway of folate involves two major enzymes, namely i) dihydropteroic acid synthase (DHPS), which forms dihydrofolate from para-aminobenzoic acid (inhibited by SMX), and ii) dihydrofolate reductase (DHFR), which catalyzes the formation of tetrahydrofolate from dihydrofolate (inhibited by TMP).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The vanB gene cluster harbor similar genes to those carried by the vanA cluster with the difference that the VanSB sensor kinase does not appear to be activated by the presence of teicoplanin.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Additionally, another phospholipid (cardiolipin, CL), seems to play an important role in the translocation of DAP oligomers from the outer of the inner leaflet, but its contribution is not completely understood.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
What the sources say
- Not checked yetcites [87] Zhang T Muraih JK Tishbi N Herskowitz J Victor RL Silverman J Uwumarenogie S Taylor SD Palmer M Mintzer E Cardiolipin prevents membrane translocation and permeabilization by daptomycin J Biol Chem 2014 4 25 289 17 11584 91 24616102 PMC4002069 source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Of note, enterococci carrying the vanEGLN clusters also produce D-Ala-D-Ser and exhibit low level of vancomycin resistance and carry similar genes to those described in vanC.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > III. Changes in Target Sites
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“This enzyme harbors two domains, i) a lysyl-transferase domain that transfers the positively-charged amino acid lysine from its tRNA carrier to PG (LPG) in the inner leaflet of the CM, and ii) a flipase domain, through which newly synthesized LPG is translocated from the inner to the outer leaflet of the CM (99).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
What the sources say
- Not checked yetcites [99] Ernst CM Kuhn S Slavetinsky CJ Krismer B Heilbronner S Gekeler C Kraus D Wagner S Peschel A The lipid-modifying multiple peptide resistance factor is an oligomer consisting of distinct interacting synthase and flippase subunits MBio 2015 6 1 pii: e02340-14 PMC4324311 25626904 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In S. aureus, MprF (a lysyl-PG [LPG] synthase) has been one of the most studied enzymes, and inactivation of this protein reversed DAP-R.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
What the sources say
- Not checked yetcites [99] Ernst CM Kuhn S Slavetinsky CJ Krismer B Heilbronner S Gekeler C Kraus D Wagner S Peschel A The lipid-modifying multiple peptide resistance factor is an oligomer consisting of distinct interacting synthase and flippase subunits MBio 2015 6 1 pii: e02340-14 PMC4324311 25626904 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Mutations in mprF appear to produce a gain of function of the enzyme and, as a result, the cell surface becomes more positively charged, repelling the DAP-calcium complex (also with positive charge).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Phenotypically, hVISA/VISA strains exhibit distinct metabolic characteristics that may include i) increase in fructose utilization, ii) increased fatty acid metabolism, iii) impaired acetate metabolism and tricarboxylic acid cycle, iv) decrease in glutamate availability, and iv) increase expression of cell wall synthesis genes.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
What the sources say
- Not checked yetcites [101] Howden BP Davies JK Johnson PD Stinear TP Grayson ML Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications Clin Microbiol Rev 2010 1 23 1 99 139 20065327 PMC2806658 source
- Not checked yetcites [104] Gardete S Tomasz A Mechanisms of vancomycin resistance in Staphylococcus aureus J Clin Invest 2014 124 7 2836 40 24983424 PMC4071404 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“LiaI is a small hydrophobic protein of unknown function with two putative transmembrane helices and LiaH is a member of the phage-shock protein family that forms large oligomeric rings-like structures (resembling what has been reported with PspA in E. coli).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
What the sources say
- Not checked yetcites [93] Wolf D Kalamorz F Wecke T Juszczak A Mäder U Homuth G Jordan S Kirstein J Hoppert M Voigt B Hecker M Mascher T In-depth profiling of the LiaR response of Bacillus subtilis J Bacteriol 2010 9 192 18 4680 93 20639339 PMC2937411 source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Furthermore, deletion of LiaR completely reverted DAP susceptibility and restored the organization of CL domains (95).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
What the sources say
- Not checked yetcites [95] Reyes J Panesso D Tran TT Mishra NN Cruz MR Munita JM Singh KV Yeaman MR Murray BE Shamoo Y Garsin D Bayer AS Arias CA A liaR Deletion Restores Susceptibility to Daptomycin and Antimicrobial Peptides in Multidrug-Resistant Enterococcus faecalis J Infect Dis 2014 10 31 pii: jiu602 PMC4402337 25362197 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interestingly, these two- and three component regulatory systems are involved in cell wall homeostasis, supporting the notion that selection of the hVISA/VISA phenotype involves important remodeling of the cell wall in order to survive the antimicrobial attack.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“This phenomenon was first reported in Japan in 1997 and led to therapeutic failure (100).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
What the sources say
- Not checked yetcites [100] Hiramatsu K Hanaki H Ino T Yabuta K Oguri T Tenover FC Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility J Antimicrob Chemother 1997 7 40 1 135 6 9249217 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“As the “resistant” subpopulation is difficult to identify, detection of hVISA becomes very challenging and some S. aureus strains reported as “susceptible” to vancomycin by standard susceptibility testing may still exhibit this phenotype (101).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
What the sources say
- Not checked yetcites [101] Howden BP Davies JK Johnson PD Stinear TP Grayson ML Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications Clin Microbiol Rev 2010 1 23 1 99 139 20065327 PMC2806658 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Hence, it has been postulated that these changes result in “trapping” of vancomycin in outer layers of the peptidoglycan preventing the antibiotic molecule from reaching its target of precursors emerging from the cytoplasmic membrane. As a result, cell wall synthesis and peptidoglycan cross-linking continues to be uninterrupted.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Published studies estimate that the overall prevalence of MRSA strains with hVISA/VISA profile range between 0 and 8.24%, but it can be as high as 30% in selected populations (e.g. patients with MRSA infective endocarditis) (102, 103).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
What the sources say
- Not checked yetcites [102] Stryjewski ME Corey GR Methicillin-resistant Staphylococcus aureus: an evolving pathogen Clin Infect Dis 2014 1 58 Suppl 1 S10 9 24343827 source
- Not checked yetcites [103] Bae IG Federspiel JJ Miró JM Woods CW Park L Rybak MJ Rude TH Bradley S Bukovski S de la Maria CG Kanj SS Korman TM Marco F Murdoch DR Plesiat P Rodriguez-Creixems M Reinbott P Steed L Tattevin P Tripodi MF Newton KL Corey GR Fowler VG Jr International Collaboration on Endocarditis-Microbiology Investigator Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance J Infect Dis 2009 200 9 1355 66 19811099 P source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In addition, VISA strains bind vancomycin more avidly than their non –VISA counterparts, however, diffusion of the antibiotic molecule into the inner part of the cell wall appears to be impaired.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
What the sources say
- Not checked yetcites [101] Howden BP Davies JK Johnson PD Stinear TP Grayson ML Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications Clin Microbiol Rev 2010 1 23 1 99 139 20065327 PMC2806658 source
- Not checked yetcites [104] Gardete S Tomasz A Mechanisms of vancomycin resistance in Staphylococcus aureus J Clin Invest 2014 124 7 2836 40 24983424 PMC4071404 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“These global homeostatic changes appear to lead to a reduced autolytic activity with thickened cell wall and an increase amount of free D-Ala-D-Ala dipeptides with less peptidoglycan cross-linking (101, 104).”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
What the sources say
- Not checked yetcites [101] Howden BP Davies JK Johnson PD Stinear TP Grayson ML Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications Clin Microbiol Rev 2010 1 23 1 99 139 20065327 PMC2806658 source
- Not checked yetcites [104] Gardete S Tomasz A Mechanisms of vancomycin resistance in Staphylococcus aureus J Clin Invest 2014 124 7 2836 40 24983424 PMC4071404 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, there seems to be a “price” to pay for developing resistance and this is yet another example of the ability of bacteria to adapt to the environment by means of their remarkable genetic plasticity.”
§ Mechanisms of Antibiotic Resistance > MECHANISTIC BASIS OF ANTIMICROBIAL RESISTANCE > IV. Resistance Due to Global Cell Adaptations
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper relies on this without support.
The environmental resistome is a prolific source for the acquisition of antibiotic resistance genes in clinically relevant bacteria.
“As mentioned before, bacteria sharing the environment with these molecules harbor intrinsic genetic determinants of resistance and there is robust evidence suggesting that such “environmental resistome” is a prolific source for the acquisition of antibiotic resistance genes in clinically relevant bacteria.”
The paper relies on this without support.
Most antimicrobial agents used in clinical practice are (or derive from) products naturally found in the environment, mostly soil.
“Most antimicrobial agents used in clinical practice are (or derive from) products naturally found in the environment (mostly soil).”
The paper relies on this without support.
The mechanism by which LiaFSR results in DAP-R is not fully understood.
“The mechanism by which LiaFSR results in DAP-R is not fully understood.”
The paper relies on this without support.
The specific mechanism through which LiaFSR orchestrates the cell-envelope response to stress is still a matter of active research.
“Furthermore, the specific mechanism through which this system orchestrates the cell-envelope response to stress is still a matter of active research.”
The paper relies on this without support.
The specific mechanisms that lead to the hVISA/VISA phenotype remain to be completely understood.
“The specific mechanisms that lead to the hVISA/VISA phenotype remain to be completely understood.”
The paper relies on this without support.
The mechanisms by which mutations in rpoB lead to reduced vancomycin and DAP susceptibility are unclear.
“However, the mechanisms by which mutation if rpoB lead to reduced vancomycin and DAP susceptibility are unclear.”
The paper relies on this without support.
The physiological role of LiaI and LiaH are not completely understood.
“The physiological role of LiaI and LiaH are not completely understood.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This oxygen-deficient setting could exert selective pressure on bacteria to develop survival mechanisms22,66, indirectly influencing the development of antibiotic resistance.”
From Impact of untreated tannery wastewater in the evolution of multidrug-resistant bacteria in Bangladesh (2024) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This increased microbial presence may contribute to an elevated probability of antibiotic resistance emergence22, as a larger number of bacteria are exposed to potential antibiotic remnants and conditions that induce resistance in the wastewater.”
From Impact of untreated tannery wastewater in the evolution of multidrug-resistant bacteria in Bangladesh (2024) · cites this paper as [22]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Bacterial antibiotic resistance can result from genetic mutations or from the acquisition of resistance through horizontal gene transfer from other strains [122].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [122]
The cited source says what the claim attributes to it.
In the citing paper
“The origin of antibiotic resistance is the process of natural selection and the innate capacity of bacteria to adapt and endure antimicrobial threats22.”
From Impact of untreated tannery wastewater in the evolution of multidrug-resistant bacteria in Bangladesh (2024) · cites this paper as [22]
In the citing paper
“In some cases, a lack of drug efficacy can be attributed to pathogen resistance, which then requires a more expensive drug regimen for cure 3 .”
From Nanotechnology approaches for global infectious diseases (2021) · cites this paper as [3]
In the citing paper
“Resistance results from the secretion of drug-inactivating enzymes and/or the pathogens switching to a state of reduced metabolic activity, forming biofilms, adopting an intracellular life cycle or being obligate intracellular pathogens 3 .”
From Nanotechnology approaches for global infectious diseases (2021) · cites this paper as [3]
In the citing paper
“These enzymes, such as β -lactamases and aminoglycoside-modifying enzymes, are readily transferred through horizontal gene transfer and have been implicated in the pattern of increasing drug resistance 3 .”
From Nanotechnology approaches for global infectious diseases (2021) · cites this paper as [3]
In the citing paper
“The evolution of antibiotic-degrading enzymes is a major mechanism causing bacterial resistance.”
From Nanotechnology approaches for global infectious diseases (2021) · cites this paper as [3]
Citations
Cites
Clinical and Laboratory Standards Institute
Gressner, A. M., & Arndt, T. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,092
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,495
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Antibiotic resistance is ancient
D’Costa, V. M., King, C. E., Kalan, L., Morar, M., Sung, W. W. L., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., et al. (2011) · Nature · doi:10.1038/nature10388 · Cited by 2,720
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,609
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,277
Mechanisms of, and Barriers to, Horizontal Gene Transfer between Bacteria
Thomas, C. M., & Nielsen, K. M. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1234 · Cited by 2,194
Flagged first, then by citations
Research works printed but not linked: 1
- The Review on Antimicrobial Resistance. 2014. Antimicrobial Resistance: Tackling a Crisis for the Future Health and Wealth of Nations. http://amr-review.org.
Cited by
Sorted by citations
Items 801–900 of 1,003
O’Hagan, S., & Kell, D. B. (2020) · Marine Drugs · doi:10.3390/md18110582 · Cited by 23
Danchik, C., Wang, S., & Karakousis, P. C. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.744167 · Cited by 23
Khuda, F., Anjum, M. S. R., Khan, S., Khan, H., Sahibzada, M. U. K., Khusro, A., Jan, A., Ullah, N., Shah, Y., Zakiullah, et al. (2021) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2021.103633 · Cited by 23
Kim, G.-J., Xu, Y., Farha, A. K., Sui, Z., & Corke, H. (2021) · Journal of Dairy Science · doi:10.3168/jds.2021-21221 · Cited by 23
Elkhalifa, M. E. M., Ashraf, M. Z., Ahmed, A., Usman, A., Hamdoon, A. A. E., Elawad, M. A., Almalki, M. G., Mosa, O. F., Niyazov, L. N., & Ayaz, M. (2024) · Future Microbiology · doi:10.2217/fmb-2023-0175 · Cited by 23
Mantovam, V. B., Santos, D., Junior, L. C. G., Landgraf, M., Pinto, U. M., & Todorov, S. D. (2025) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2024.0124 · Cited by 24
Hellewell, L., & Bhakta, S. (2020) · Access Microbiology · doi:10.1099/acmi.0.000105 · Cited by 22
Higgins, D., Mukherjee, N., Pal, C., Sulaiman, I. M., Jiang, Y., Hanna, S., Dunn, J. R., Karmaus, W., & Banerjee, P. (2020) · Microorganisms · doi:10.3390/microorganisms8101465 · Cited by 22
Vidallon, M. L. P., & Teo, B. M. (2020) · Chemical Communications · doi:10.1039/d0cc05880g · Cited by 22
Ochoa‐Grullón, J., Cuesta, C. B., Fernandez, A. F. G., Torres, G. C., López, C. P., Cortijo, A. P., Conejero, L., Morales, M. M., de la Peña, A. R., Diez-Rivero, C. M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.611566 · Cited by 22
Mengistu, T. S., Garcias, B., Castellanos, G., Seminati, C., Molina‐López, R. A., & Darwich, L. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.154814 · Cited by 22
Kim, J., Kim, J., & Ahn, J. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105576 · Cited by 22
Recent Developments to Cope the Antibacterial Resistance via β-Lactamase Inhibition
Iqbal, Z. M., Sun, J., Yang, H., Ji, J., He, L., Zhai, L., Ji, J., Zhou, P., Tang, D., Mu, Y., et al. (2022) · Molecules · doi:10.3390/molecules27123832 · Cited by 22
Jorge, G. P., Goes, I. C. R. D. S., & Gontijo, M. T. P. (2022) · Current Infectious Disease Reports · doi:10.1007/s11908-022-00788-z · Cited by 22
Benzoic acid derivatives as potent antibiofilm agents against Klebsiella pneumoniae biofilm
Rohatgi, A., & Gupta, P. (2023) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2023.06.011 · Cited by 22
Nain, A., Tseng, Y., Gupta, A., Lin, Y., Sangili, A., Huang, Y., Huang, C., & Chang, H. (2023) · Nanoscale Horizons · doi:10.1039/d3nh00275f · Cited by 22
Coluzzi, C., Guillemet, M., Mazzamurro, F., Touchon, M., Godfroid, M., Achaz, G., Glaser, P., & Rocha, E. P. C. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad217 · Cited by 22
Harutyunyan, A., Gabrielyan, L. S., Aghajanyan, A., Gevorgyan, S., Schubert, R., Betzel, C., Kujawski, W. M., & Gabrielyan, L. S. (2024) · ACS Omega · doi:10.1021/acsomega.4c01604 · Cited by 22
Integrative genomics would strengthen AMR understanding through ONE health approach
Liu, C. S. C., & Pandey, R. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34719 · Cited by 23
Transcriptional Regulators: Valuable Targets for Novel Antibacterial Strategies
González, A., Fillat, M. F., & Lanas, Á. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0181 · Cited by 22
Efiana, N. A., Dizdarević, A., Huck, C. W., & Bernkop‐Schnürch, A. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.05.020 · Cited by 22
Silver, R. J., Paczosa, M. K., McCabe, A. L., Balada-Llasat, J.-M., Baleja, J., & Mecsas, J. C. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02674-18 · Cited by 22
An Efficient Computational Assay for β-Lactam Antibiotic Breakdown by Class A β-Lactamases
Hirvonen, V. H. A., Hammond, K., Chudyk, E. I., Limb, M. A. L., SPENCER, J. M., Mulholland, A. J., & van der Kamp, M. W. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00442 · Cited by 22
Chen, B., & Xu, W. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008108 · Cited by 22
The contribution of nano‐based strategies in overcoming ceftriaxone resistance: a literature review
Yayehrad, A. T., Marew, T., & Birhanu, G. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.849 · Cited by 22
Mahmud, Z., Manik, M. R. K., Rahman, A., Karim, M. M., & Islam, L. N. (2024) · Scientific Reports · doi:10.1038/s41598-024-71472-6 · Cited by 22
Safety of Probiotics in Health and Disease
Daliri, E. B.-M., Lee, B. H., & Oh, D. H. (2019) · The Role of Functional Food Security in Global Health · doi:10.1016/b978-0-12-813148-0.00034-7 · Cited by 21
Fan, X., Qadeer, A., Asiri, M., Alzahrani, F. M., Alzahrani, K. J., Alsharif, K. F., Khan, M. Z., & Jiang, X. P. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1642647 · Cited by 21
Ahmed, N., Abusalah, M. A. H., & Abuarqoub, A. H. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s547259 · Cited by 23
SILVA, V. Y. N. E. D., Correia, S., Pereira, J. E., Igrejas, G., & Poeta, P. A. C. Q. D. (2020) · Emerging contaminants and associated treatment technologies · doi:10.1007/978-3-030-40422-2_13 · Cited by 21
Yalew, S. T. (2020) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2020.24.004121 · Cited by 21
Fitness Cost of Antibiotic Resistance in Staphylococcus aureus : A Systematic Review
Touati, A., Bellil, Z., Barache, D., & Mairi, A. (2021) · Microbial Drug Resistance · doi:10.1089/mdr.2020.0426 · Cited by 21
Mao, J., Miscevic, D., Unnikrishnan, B., Chu, H., Chou, C.-H. P., Chang, L., Lin, H. ‐., & Huang, C. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.10.107 · Cited by 21
Perbandt, M., Werner, N., Prester, A., Rohde, H., Aepfelbacher, M., Hinrichs, W., & Betzel, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-09392-6 · Cited by 21
Naha, A., & Ramaiah, S. (2022) · 3 Biotech · doi:10.1007/s13205-022-03325-w · Cited by 21
Bacterial drug resistance towards natural products
Seukep, A. J., Nembo, E. N., Mbuntcha, H. G., & Kuete, V. (2022) · Advances in botanical research · doi:10.1016/bs.abr.2022.08.002 · Cited by 22
Removal of antimicrobial resistance from secondary treated wastewater – A review
Pant, A., Shahadat, M., Ali, S., & Ahammad, S. Z. (2022) · Journal of Hazardous Materials Advances · doi:10.1016/j.hazadv.2022.100189 · Cited by 21
Amin, M. T., Aty, M. A. A. E., Ahmed, S. M., Elsedfy, G. O., Hassanin, E. S. A., & El-Gazzar, A. F. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277308 · Cited by 21
Tabcheh, J., Vergalli, J., Davin‐Regli, A., Ghanem, N., Pagès, J., Al-Bayssari, C., & Brunel, J. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021515 · Cited by 21
Adaszyńska-Skwirzyńska, M., Zych, S., Bucław, M., Majewska, D., Dzięcioł, M., & Szczerbińska, D. (2023) · Molecules · doi:10.3390/molecules28155781 · Cited by 21
Metal nanoparticles as inhibitors of enzymes and toxins of multidrug-resistant Staphylococcus aureus
Joshi, A., & Patil, R. H. (2023) · Infectious Medicine · doi:10.1016/j.imj.2023.11.006 · Cited by 21
Impacts of coprophagic foraging behaviour on the avian gut microbiome
Dunbar, A., Drigo, B., Djordjevic, S. P., Donner, E., & Hoye, B. J. (2023) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.13036 · Cited by 21
Combating Antimicrobial Resistance: A paradigm shift from general to precision medicine
Ahmed, F., Shamim, N. J., Das, A., Sharma, H. K., Grewal, A. S., Pandita, D., & Lather, V. (2024) · Chemical Biology Letters · doi:10.62110/sciencein.cbl.2024.v11.662 · Cited by 21
Interaction of cationic antimicrobial peptides from Australian frogs with lipid membranes
Zhu, S., Sani, M., & Separovic, F. (2018) · Peptide Science · doi:10.1002/pep2.24061 · Cited by 22
Strich, J. R., & Kadri, S. S. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1696662 · Cited by 21
Subsistence and complexity of antimicrobial resistance on a community‐wide level
Perri, R., Kolvenbach, B. A., & Corvini, P. F.-X. (2020) · Environmental Microbiology · doi:10.1111/1462-2920.15018 · Cited by 21
Combination therapy against multidrug resistance
Marimani, M. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820576-1.00002-3 · Cited by 21
Gupta, Y. D., & Bhandary, S. (2024) · Wiley eBooks · doi:10.1002/9781394234196.ch5 · Cited by 21
Cellular thermal shift assay: an approach to identify and assess protein target engagement
Zhang, L., Wang, Y., Chang, Z., Zhou, Z., & Chen, Z. (2024) · Expert Review of Proteomics · doi:10.1080/14789450.2024.2406785 · Cited by 20
Koul, V., Sharma, A., Kumari, D., Jamwal, V., Palmo, T., & Singh, K. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-04205-y · Cited by 20
High-throughput method characterizes hundreds of previously unknown antibiotic resistance mutations
Jago, M. J., Soley, J. K., Denisov, S., Walsh, C. J., Gifford, D. R., Howden, B. P., & Lagator, M. (2025) · Nature Communications · doi:10.1038/s41467-025-56050-2 · Cited by 20
Shi, Y., Luo, G., Zhen, B., Liu, Z., Chen, S., Wang, Z., Lu, W., Hu, H., & Li, X. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02852 · Cited by 21
Harder than Metal: Challenging Antimicrobial Resistance with Metallo-β-lactamase Inhibitors
de Falco, A., Alfano, A. I., Cutarella, L., Mori, M., & Brindisi, M. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00553 · Cited by 20
Purification and characterization of nisin P produced by a strain of Streptococcus gallolyticus
Aldarhami, A., Felek, A., Sharma, V., & Upton, M. (2020) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001170 · Cited by 21
Survey and Sequence Characterization of Bovine Mastitis-Associated Escherichia coli in Dairy Herds
Alawneh, J. I., Vezina, B., Ramay, H. R., Al-harbi, H., Ameh, J. A., Soust, M., Moore, R. J., & Olchowy, T. W. J. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.582297 · Cited by 20
Chakraborty, A., Haque, S. M., Dey, D., Mukherjee, S., & Ghosh, B. (2022) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-022-00414-4 · Cited by 20
Bhattacharya, S., Sen, D., & Bhattacharjee, C. (2022) · Process Biochemistry · doi:10.1016/j.procbio.2022.09.026 · Cited by 20
Ma, X., Hao, Y., Mao, R., Yang, N., Zheng, X., Li, B., Wang, X., Zhang, Q., Teng, D., & Wang, J. (2022) · BioMetals · doi:10.1007/s10534-022-00461-x · Cited by 21
Alam, G. S., Hassan, M. M., Ahaduzzaman, M., Nath, C., Dutta, P., Khanom, H., Khan, S. A., Pasha, M. R., Islam, A., Magalhães, R. J. S., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12020418 · Cited by 20
Allel, K., Labarca, J. A., Carvajal, C., Garcia, P., Cifuentes, M., Silva, F., Munita, J. M., & Undurraga, E. A. (2023) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2023.100484 · Cited by 23
Self-citationPulmonary delivery systems for antimicrobial peptides
Caselli, L., Rodrigues, G. R., Franco, O. L., & Malmsten, M. (2023) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2023.2254932 · Cited by 20
Sykes, E. M. E., Mateo-Estrada, V., Engelberg, R., Muzaleva, A., Zhanel, G. G., Dettman, J. R., Chapados, J. T., Gerdis, S., Akineden, Ö., Khan, I. U. H., et al. (2024) · mSphere · doi:10.1128/msphere.00741-23 · Cited by 20
Antimicrobial Stewardship: A Correct Management to Reduce Sepsis in NICU Settings
Notarbartolo, V., Badiane, B. A., Insinga, V., & Giuffrè, M. (2024) · Antibiotics · doi:10.3390/antibiotics13060520 · Cited by 20
Fritz, R. A., Alzate‐Morales, J. H., SPENCER, J. M., Mulholland, A. J., & van der Kamp, M. W. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00480 · Cited by 20
Kim, M. K., Lee, T., Jung, M., Park, K., & Chong, Y. (2018) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c18-00380 · Cited by 20
Hoeksema, M., Jonker, M. J., Bel, K., Brul, S., & ter Kuile, B. H. (2018) · BMC Genomics · doi:10.1186/s12864-018-5353-y · Cited by 20
Matange, N., Hegde, S., & Bodkhe, S. (2019) · Genetics · doi:10.1534/genetics.119.301834 · Cited by 20
Low prevalence of resistance genes in sheltered homeless population in Marseille, France, 2014–2018
Ly, T. D. A., Hadjadj, L., Hoang, V. T., Louni, M., Dao, T. L., Badiaga, S., Tissot‐Dupont, H., Raoult, D., Rolain, J., & Gautret, P. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s202048 · Cited by 20
Varma, G. Y. N., Kummari, G., Paik, P., & Kalle, A. M. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz391 · Cited by 20
Temporal encoding of bacterial identity and traits in growth dynamics
Zhang, C., Song, W., Ma, H. R., Peng, X., Anderson, D. J., Fowler, V. G., Thaden, J. T., Xiao, M., & You, L. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008807117 · Cited by 20
Drug Discovery for Targeting Drug Resistant Bacteria
Valsamatzi-Panagiotou, A., Popova, K. B., & Prof. Robert Penchovsky, D. R. N. (2020) · Sustainable agriculture reviews · doi:10.1007/978-3-030-53024-2_9 · Cited by 20
İnce, B. T., Gültekinoğlu, M., Timur, S. S., Eroğlu, İ., Ulubayram, K., & Eroğlu, H. (2020) · Journal of drug targeting · doi:10.1080/1061186x.2020.1867991 · Cited by 20
Krivitskaya, A. V., & Khrenova, M. G. (2021) · Molecules · doi:10.3390/molecules26072026 · Cited by 20
Sahulka, S. Q., Bhattarai, B., Bhattacharjee, A. S., Tanner, W. D., Mahar, R. B., & Goel, R. K. (2021) · Water Research · doi:10.1016/j.watres.2021.117480 · Cited by 20
Advancement towards Antibiotic Remediation: Heterostructure and Composite materials
Bhattacharyya, P., Basak, S., & Chakrabarti, S. (2021) · ChemistrySelect · doi:10.1002/slct.202100436 · Cited by 20
Haq, S. U., Ling, W., Aqib, A. I., Danmei, H., Aleem, M. T., Fatima, M., Ahmad, S., & Gao, F. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177511 · Cited by 19
Leroux, P., Bornet, C., Bolla, J., & Cohen, A. (2025) · Antibiotics · doi:10.3390/antibiotics14060587 · Cited by 19
Cocker, D., Mwapasa, T., Grabic, R., Grabicová, K., Staňová, A. V., Chidziwisano, K., Roberts, A. P., Morse, T., Feasey, N., & Singer, A. C. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00149-5 · Cited by 20
Chigozie, V. U., Aniokete, U. C., Ogbonna, I. P., & Iroha, R. I. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-07053-7 · Cited by 21
Drane, K., Huerlimann, R., Power, M. L., Whelan, A., Ariel, E., Sheehan, M., & Kinobe, R. T. (2021) · Antibiotics · doi:10.3390/antibiotics10070775 · Cited by 19
Han, D., Li, X., Bian, X., Wang, J., Kong, L., Ding, S., & Yan, Y. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.131120 · Cited by 19
Expressions of resistome is linked to the key functions and stability of active rumen microbiome
Ma, T., Zaheer, R., McAllister, T. A., Guo, W., Li, F., Tu, Y., Diao, Q., & Guan, L. L. (2022) · Animal Microbiome · doi:10.1186/s42523-022-00189-6 · Cited by 21
Panda, G., Dash, S., & Sahu, S. K. (2022) · Membranes · doi:10.3390/membranes12100914 · Cited by 19
Lian, Q., Zheng, S., Shi, Z., Li, K., Chen, R., Wang, P., Liu, H., Chen, Y., Zhong, Q., Liu, Q., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.10.033 · Cited by 19
Nigericin is effective against multidrug resistant gram-positive bacteria, persisters, and biofilms
Zhu, X., Hong, A., Sun, X., Wang, W., He, G., Luo, H., Wu, Z., Xu, Q., Hu, Z., Wu, X., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1055929 · Cited by 19
Ramírez-Bayard, I. E., Mejía, F., Medina-Sánchez, J. R., Cornejo-Reyes, H., Castillo, M., Querol‐Audí, J., & Martínez-Torres, A. O. (2023) · Antibiotics · doi:10.3390/antibiotics12020280 · Cited by 21
Edris, S. N., Hamad, A. M. A., Awad, D. A. B., & Sabeq, I. I. (2023) · Veterinary World · doi:10.14202/vetworld.2023.403-413 · Cited by 19
Tian, C., Yuan, M., Tao, Q., Xu, T., Liu, J., Huang, Z., Wu, Q., Pan, Y., Zhao, Y., & Zhang, Z. (2023) · Antibiotics · doi:10.3390/antibiotics12040638 · Cited by 19
Antibiotic-Induced Dysbiosis of the Gut Microbiota Impairs Gene Expression in Gut-Liver Axis of Mice
Liu, P., Zhang, Y., Zhang, Z., Huang, X., Su, X., Yang, S., & Xie, Y. (2023) · Genes · doi:10.3390/genes14071423 · Cited by 19
Jia, Y., Schroeder, B., Pfeifer, Y., Fröhlich, C., Deng, L., Arkona, C., Kuropka, B., Sticht, J., Ataka, K., Bergemann, S., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00171 · Cited by 19
Heine, N., Doll‐Nikutta, K., Stein, F., Jakobi, J., Ingendoh‐Tsakmakidis, A., Rehbock, C., Winkel, A., Barcikowski, S., & Stiesch, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-53782-x · Cited by 19
Koner, S., Chen, J.-S., Hseu, Z., Chang, E., Chen, K., Asif, A., & Hsu, B. (2024) · Journal of Environmental Management · doi:10.1016/j.jenvman.2024.121688 · Cited by 19
Evaluation of studies on extended versus standard infusion of beta-lactam antibiotics
Chen, M., Buurma, V., Shah, M., & Fahim, G. (2019) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxz154 · Cited by 19
Does the Future of Antibiotics Lie in Secondary Metabolites Produced by Xenorhabdus spp.? A Review
Booysen, E., & Dicks, L. M. T. (2020) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-020-09688-x · Cited by 20
Milaković, M., Križanović, S., Petrić, I. S., Šimatović, A., Plaza, J. J. G., Gužvinec, M., Andrašević, A. T., Pole, L., Fuka, M. M., & Udiković‐Kolić, N. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.142357 · Cited by 19
Yin, J., Cheng, D., Zhu, Y., Liang, Y., & Yu, Z. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-11762-z · Cited by 19
KOÇAK, Y., Oto, G., Meydan, İ., SEÇKİN, H., Gür, T., Aygün, A., & Şen, F. (2022) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2022.109417 · Cited by 19
Rızvanoğlu, S. S., Kart, D., & Eryılmaz, M. (2022) · Archives of Microbiology · doi:10.1007/s00203-022-02853-6 · Cited by 19
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac111.81908203 · Cited by 19
Structural basis for HflXr-mediated antibiotic resistance in Listeria monocytogenes
Koller, T. O., Turnbull, K. J., Vaitkevicius, K., Crowe‐McAuliffe, C., Roghanian, M., Bulvas, O., Nakamoto, J. A., Kurata, T., Julius, C., Atkinson, G. C., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac934 · Cited by 19
Metadata
- Authors
- Munita, J. M., & Arias, C. A.
- Affiliations
- Universidad del Desarrollo (CL)
- Department of Internal Medicine, Division of Infectious Diseases, University of Texas Medical School at Houston, Houston, TX 77030
- ORCID
- Munita, Jose M.
- Venue
- Microbiology Spectrum
- Publisher
- American Society for Microbiology
- Published
- 2016-03-25
- Volume
- 4
- Issue
- 2
- ISSN
- 2165-0497 (ISSN-L)
- PMC
- PMC4888801
- OpenAlex
- W2316777574
- Semantic Scholar
- 01497a249ba66aa180d77269f1f01d9c4b798063
- Cited by
- 2,782
- References
- 110
- Citations by year
- 2026: 213 · 2025: 315 · 2024: 359 · 2023: 386 · 2022: 379 · 2021: 374 · 2020: 337 · 2019: 265 · 2018: 124 · 2017: 17 · 2016: 6
- FWCI
- 8.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Microbiology Spectrum (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Repositorio Institucional Universidad El Bosque (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI093749)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- antibiotic resistance mechanisms, multidrug-resistant bacteria, bacterial adaptation, genome plasticity, bacterial evolution, community-acquired resistance, nosocomial infections, pathogenic bacteria, resistance gene acquisition, gene expression regulation
- MeSH terms
- Adaptation, Physiological, Anti-Bacterial Agents, Bacteria, Bacterial Infections, Drug Resistance, Microbial, Humans, Mutation, Drug Resistance, Multiple, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review